Tests herbal medicine Qurs e Fishar for mild to moderate high blood pressure
Tests an herbal medicine, Qurs e Fishar, in adults with mild to moderate hypertension.
Plain-language title generated from the registry record
Registry title: Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
Key facts
- Where
- Karachi, PakistanSee the site
- Phase
- Phase 3
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 60 years old?
Source: NCT06852079, who can take part
Where in Pakistan
- Taj Medical Complex, Hamdard University HospitalKarachi, PakistanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Abdul Bari
- Trial code
- NCT06852079
- Record updated
- 28 February 2025
- Original description
The herbal medicine Qurs-e-Fishar to treat mild to moderate High blood pressure or hypertension comprises of Rauwolfia serpentina. A product of Hamdard Laboratories (Waqf) Pakistan.Read full original descriptionShow less
Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
The herbal medicine Qurs-e-Fishar to treat mild to moderate High blood pressure or hypertension comprises of Rauwolfia serpentina. A product of Hamdard Laboratories (Waqf) Pakistan.
A Phase III Safety \& Efficacy Open-label, Single-Arm, Interventional, Multicenter, Study in mild to moderate hypertensive, adults (30 to 60 years of age) prescribed with study product for 12 weeks (84 days).
Primary End Points:
1. Reduction in diastolic blood pressure less than 130 / 80 mmHg at the end of the study period (accepted by WHO) or if there was a fall of 20 / 10 mmHg or more in diastolic blood pressure as compared to baseline. 2. Type, frequency and severity of ADRs during the study period.
Secondary End Points:
1. Compliance of the prescribed study medication.
Inclusion: Ability to sign ICD; Participant(s) are willing and able to fulfill the requirements of the study protocol; Mild to moderate hypertensive; Mild hypertension range (140-159/90-99 mm Hg); Moderate hypertension range (160-179/100-109 mm Hg); Be between the age of 30 to 60 year.
Exclusion: Patients with recent history of following will be excluded:; Severe hypertension,; Congestive cardiac failure,; Left ventricular failure,; Myocardial ischemia,; Renal failure or; Cerebrovascular accidents.